TickerFacts.

A business in context

FDMT research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-20 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-10-05 · 0001193125-26-417068

  2. 8-K · Current report

    Report date 2026-09-28 · 0001193125-26-403424 · Items 8.01

  3. 4 · Ownership change

    Report date 2026-09-16 · 0001193125-26-398204

  4. 4 · Ownership change

    Report date 2026-09-14 · 0001193125-26-393243

  5. 4 · Ownership change

    Report date 2026-09-01 · 0001193125-26-382245

  6. 4 · Ownership change

    Report date 2026-08-19 · 0001193125-26-361096

  7. 4 · Ownership change

    Report date 2026-08-13 · 0001193125-26-354313

  8. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-349173

  9. 8-K · Current report

    Report date 2026-08-13 · 0001193125-26-349160 · Items 2.02

  10. 4 · Ownership change

    Report date 2026-08-04 · 0001193125-26-335115

  11. 4 · Ownership change

    Report date 2026-08-03 · 0001193125-26-333014

  12. 8-K · Current report

    Report date 2026-07-18 · 0001193125-26-308409 · Items 8.01

  13. 8-K · Current report

    Report date 2026-06-24 · 0001193125-26-286880 · Items 1.01,2.03

  14. 8-K · Current report

    Report date 2026-06-17 · 0001193125-26-277563 · Items 5.07

  15. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-211939

  16. 8-K · Current report

    Report date 2026-05-07 · 0001193125-26-211904 · Items 2.02,9.01

  17. DEF 14A · Proxy statement

    Report date 2026-06-17 · 0001140361-26-017427

  18. 8-K · Current report

    Report date 2026-03-25 · 0001193125-26-131739 · Items 5.02

  19. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-114075

  20. 8-K · Current report

    Report date 2026-03-18 · 0001193125-26-113949 · Items 2.02,9.01

  21. 8-K · Current report

    Report date 2026-01-22 · 0001193125-26-022559 · Items 3.02,9.01

  22. 8-K · Current report

    Report date 2025-12-31 · 0001193125-26-005470 · Items 2.02,5.02

  23. 8-K · Current report

    Report date 2025-12-10 · 0001193125-25-314167 · Items 8.01

  24. 8-K · Current report

    Report date 2025-11-17 · 0001193125-25-283861 · Items 5.02

  25. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-273343

  26. 8-K · Current report

    Report date 2025-11-10 · 0001193125-25-273340 · Items 2.02,9.01

  27. 8-K · Current report

    Report date 2025-11-06 · 0001193125-25-272286 · Items 8.01,9.01

  28. 8-K · Current report

    Report date 2025-11-06 · 0001193125-25-267934 · Items 2.02,8.01

  29. 8-K · Current report

    Report date 2025-10-31 · 0001193125-25-259302 · Items 1.01

  30. 8-K · Current report

    Report date 2025-09-30 · 0001193125-25-228289 · Items 5.02,5.03,9.01

  31. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-106244

  32. 8-K · Current report

    Report date 2025-08-11 · 0000950170-25-106243 · Items 2.02,9.01

  33. 8-K · Current report

    Report date 2025-06-27 · 0000950170-25-092964 · Items 5.02,8.01

  34. 8-K · Current report

    Report date 2025-06-17 · 0000950170-25-088482 · Items 5.07

  35. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-067040

  36. 8-K · Current report

    Report date 2025-05-08 · 0000950170-25-067013 · Items 2.02,9.01

  37. DEF 14A · Proxy statement

    Report date 2025-06-17 · 0001140361-25-016307

  38. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-030056

  39. 8-K · Current report

    Report date 2025-02-28 · 0000950170-25-030020 · Items 2.02,9.01

  40. 8-K · Current report

    Report date 2025-02-08 · 0000950170-25-016708 · Items 8.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 13 transaction rows13SGrant / award: 0 transaction rows0AExercise / conversion: 14 transaction rows14MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

27 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-16
2026-09-22
Bizily ScottM · Exercise / conversion
Acquired
Common Stock1635.04.14
2026-09-16
2026-09-22
Bizily ScottS · Sale
Disposed
Common Stock1635.013.65
2026-09-16
2026-09-22
Bizily ScottM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
1635.00.0
2026-09-14
2026-09-16
Kirn DavidS · Sale
Disposed
Common Stock58333.013.9
2026-09-01
2026-09-03
Bizily ScottS · Sale
Disposed
Common Stock584.014.0
2026-09-01
2026-09-03
Bizily ScottM · Exercise / conversion
Acquired
Common Stock584.06.49
2026-09-01
2026-09-03
Bizily ScottM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
584.00.0
2026-08-19
2026-08-21
Kirn DavidS · Sale
Disposed
Common Stock43149.015.36
2026-08-19
2026-08-21
Kirn DavidS · Sale
Disposed
Common Stock25927.016.42
2026-08-19
2026-08-21
Kirn DavidM · Exercise / conversion
Acquired
Common Stock50000.04.14
2026-08-19
2026-08-21
Kirn DavidM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
50000.00.0
2026-08-17
2026-08-17
Bizily ScottS · Sale
Disposed
Common Stock1635.012.2
2026-08-17
2026-08-17
Bizily ScottM · Exercise / conversion
Acquired
Common Stock1635.04.14
2026-08-17
2026-08-17
Bizily ScottM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
1635.00.0
2026-08-13
2026-08-17
Bizily ScottM · Exercise / conversion
Acquired
Common Stock1635.04.14
2026-08-13
2026-08-17
Bizily ScottS · Sale
Disposed
Common Stock1635.012.0
2026-08-13
2026-08-17
Bizily ScottM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
1635.00.0
2026-08-04
2026-08-05
Kirn DavidS · Sale
Disposed
Common Stock26842.010.23
2026-08-03
2026-08-04
Kirn DavidS · Sale
Disposed
Common Stock12415.010.05
2026-07-10
2026-07-14
Kirn DavidS · Sale
Disposed
Common Stock15283.012.01
2026-07-10
2026-07-14
Kirn DavidS · Sale
Disposed
Common Stock442.012.84
2026-07-09
2026-07-14
Kirn DavidS · Sale
Disposed
Common Stock42608.012.87
2026-06-30
2026-07-02
Bizily ScottM · Exercise / conversion
Acquired
Common Stock5752.06.49
2026-06-30
2026-07-02
Bizily ScottM · Exercise / conversion
Acquired
Common Stock814.04.14
2026-06-30
2026-07-02
Bizily ScottS · Sale
Disposed
Common Stock6566.014.0
2026-06-30
2026-07-02
Bizily ScottM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
5752.00.0
2026-06-30
2026-07-02
Bizily ScottM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
814.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 00016506484D Molecular Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names
  • 4D Molecular Therapeutics Inc. · former SEC name · 2020-07-21 to 2022-05-12
  • 4D Molecular Therapeutics Inc · former SEC name · 2015-08-13 to 2019-09-30

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$37.0K$39.7K
2023-12-31$20.72M$22.91M
2022-12-31$3.13M$3.60M
2021-12-31$18.04M$22.43M
2020-12-31$13.36M$17.40M
2019-12-31$6.96M$9.17M

Bureau of Labor Statistics · retrieved 2026-10-20 · 9 selected series; gaps remain missing

Explore the CPI history ↗